CommercialCoverageMedium impact
06.02.06s, Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations (Independence Administrators)
Independence Blue Cross·Oncology, OB-GYN, Family Medicine +1 more·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Administrators has updated their medical policy for genetic testing for inherited BRCA1 and BRCA2 mutations, effective January 1, 2025. This policy change affects commercial plan coverage criteria and billing requirements for hereditary breast cancer genetic testing.
Action Required
Immediately: Billing team must review updated BRCA1/BRCA2 genetic testing coverage criteria for Independence Administrators commercial plans. Verify current prior authorization requirements and coverage guidelines by accessing the full policy at the source URL. Update billing workflows to ensure compliance with new coverage criteria effective January 1, 2025.